Feb. 15 is International Angelman Syndrome Day, and the Synk family aims to raise awareness and honor people with the rare ...
Hosted on MSN16h
The special reason Terminal Tower will be blue on SaturdayFeb. 15 is International Angelman Syndrome Day, and the Synk family aims to raise awareness and honor people with the rare ...
Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug.
Dr. Eric Levine’s cutting-edge autism research at UConn School of Medicine is reprogramming the donated skin or blood cells ...
WTIC Hartford on MSN5d
Connecticut college receives $400K for autism research from Philadelphia Eagles foundationThis is one of 22 cutting-edge projects selected to share in a total of $8.1 million in grants raised through the Eagles ...
to treat Angelman syndrome (AS). "This program has consistently delivered remarkable animal data, reinforcing its potential as a groundbreaking treatment," said Dr. Donald Kohn, Distinguished ...
The data to date, funded by TransformaTx Biotherapeutics, a biotechnology company founded by the Foundation for Angelman Syndrome Therapeutics (FAST), has demonstrated complete symptomatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback